4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-018748
President and CEO acquired 7,541 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn President and CEO | 2025-06-30 | Grant or award | +7,541 | $1.70 | $12,820 | 18,028 | D |
Loading xslF345X05/form4-07012025_090724.xml…